Latest News
14-May-2026 Regulator Reviews Norms on Use of High-risk Solvents in Syrups
13-May-2026 Hospitals Warn CGHS Reimbursement Cap may Hurt Cancer Treatment
13-May-2026 DRL Plans to Roll Out Oral Semaglutide Generic Soon
08-May-2026 Torrent Takes Lead in Semaglutide Race with 38% Mkt Share
05-May-2026 Pharma Exports Surpass $31 b in FY26 Despite Global Headwinds
  more...
Latest Reports
Apr-26 Doors set to open for generic semaglutide in Canada - ICICI Securities  
Apr-26 Bed rock of growth: Structural strength meets strategic expansion - ICICI Securities  
Apr-26 IPM: 11% growth in Mar-26; 10% in FY26 - HDFC Securities  
Apr-26 US tariffs on branded drugs; generics exempted - HDFC Securities  
Mar-26 Pharma Weekly - ICYMI - Emkay Research  
  more...

Quarterly Summary December-2025
Desc Current Previous Per.Chg
Sales 71509.6 68692.6 4.1
Otherincome 3350.6 2183.9 53.4
Expense 55673.2 52756.3 5.5
RawMaterial 21180.1 20771.5 2.0
StaffCost 11940.7 10544.5 13.2
ExciseDuty 21.5 65.6 -67.2
OtherExp 16606.2 16205.3 2.5
Interest 1296.7 1399.2 -7.3
GrossProfit 18498.7 18194.1 1.7
Depreciation 3228.6 2930.7 10.2
Tax 3037.9 3072.0 -1.1
NetProfit 10307.2 12835.8 -19.7
Total.Comp 192 -- --
Source: ETIG Database

Sectoral Companies As on 13 May 2026
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 437728.29
Divi's Lab 180298.95
Torrent Phar 145366.75
Cipla 107207.18
Dr.Reddy's 105597.90
Lupin 101290.37
Mankind Phar 99377.47
Zydus Life 94477.15
Aurobindo Ph 86977.70
Laurus Labs 69122.39
Biocon 67713.10
Alkem Labora 65214.53
Glenmark Pha 64290.80
  click here for the complete list